載入...
Bordetella pertussis Isolates with a Heterogeneous Phenotype for Erythromycin Resistance
Erythromycin is currently being used for both prophylaxis and treatment of pertussis infections. Erythromycin resistance was first recognized in Bordetella pertussis in Arizona in 1994, and since then, three additional resistant isolates have been identified in the United States. To better assess th...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Microbiology
2002
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC120648/ https://ncbi.nlm.nih.gov/pubmed/12149356 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.40.8.2942-2944.2002 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|